SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-18-009606
Filing Date
2018-07-25
Accepted
2018-07-25 09:21:01
Documents
3
Period of Report
2018-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k072018_soligenixinc.htm 8-K 33951
2 PRESS RELEASE ISSUED BY SOLIGENIX, INC. ON JULY 24, 2018 f8k072018ex99-1_soligenixinc.htm EX-99.1 13958
3 GRAPHIC ex99-1_001.jpg GRAPHIC 21870
  Complete submission text file 0001213900-18-009606.txt   79710
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 18967815
SIC: 2834 Pharmaceutical Preparations